Radiopharm Theranostics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL 2022-10-19 11:12
MD ANDERSON AND RADIOPHARM THERANOSTICS LAUNCH JOINT VENTURE TO DEVELOP NOVEL RADIOPHARMACEUTICALS 2022-09-14 11:09
RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB 2022-08-04 10:15
RAD adds brain tumor technology to portfolio 2022-06-10 10:21
1